JPRN-jRCT2080223324已完成1 期
Clinical Pharmacology Study of CS-3150 Drug-drug interaction study between CS-3150 and amlodipine in healthy Japanese subjects
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 44
研究概览
简要总结
In study 1, the pharmacokinetics of esaxerenone was not affected by amlodipine when esaxerenone 2.5 mg was coadministered with amlodipine 10 mg. In study 2, AUC for amlodipine was increased by approximately 1.2 fold, but Cmax for amlodipine was not increased when amlodipine 2.5 mg was coadministered with esaxerenone 5 mg. It was considered that there were no safety concerns when esaxerenone was administered concomitantly with amlodipine.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 45age old(—)
- 性别
- Male
入选标准
- •1)Japanese male
- •2)Persons >= 20 years and =< 45 years of age at the time of informed consent
- •3)Persons with a body mass index (BMI; calculated by body weight [kg]/height [m]2) of >= 18.5 kg/m2 and < 25.0 kg/m2 at the screening examination
排除标准
- •1)Persons with hypersensitivity or idiosyncratic reactions to a drug, (such as penicillin allergy)
- •2)Persons with drug or alcohol dependence
研究者
相似试验
已完成
1 期
Clinical Pharmacology Study of CS-3150 Evaluation of the effect of repeated dose of itraconazole orally administered to healthy Japanese adult male on the pharmacokinetics of CS-3150Healthy volunteersJPRN-jRCT2080223231DAIICHI SANKYO Co.,Ltd.20
已完成
1 期
CS-3150 midazolam DDI studyHealthy volunteersJPRN-jRCT2080222780DAIICHISANKYO Co.,Ltd.28
已完成
1 期
A Phase 1 Study of CS-3150 Evaluation of Safety, Pharmacokinetics, and Pharmacodynamics after Single Oral Administration in Japanese Healthy Adult Male SubjectsHealthy volunteersJPRN-jRCT2080223418DAIICHI SANKYO Co.,Ltd.48
已完成
1 期
Clinical Pharmacology Study of CS-3150 A single dose study to assess the absolute bioavailability and effect of food on the pharmacokinetics of CS-3150 in Japanese healthy subjectsHealthy volunteersJPRN-jRCT2080223397DAIICHI SANKYO Co.,Ltd.24
已完成
3 期
Study of CS-3150 in Patients With Essential HypertensionEssential HypertensionNCT02890173Daiichi Sankyo Co., Ltd.1,001
